• Lorcaserin and Phentermine Combo for Weight Management

    by Scott Isaacs, MD
    on May 12th, 2018

In the May 2017 issue of Obesity, Steven Smith, M.D. and coauthors performed a pilot study in 235 patients to assess the short-term tolerability of lorcaserin 10 mg twice daily monotherapy or when combined with phentermine 15 mg once daily or twice daily. Patients were assessed for weight loss over a 12 week period as well as potentially serotonergic adverse events (dry mouth, headache, dizziness, fatigue, insomnia, nausea, diarrhea, vomiting and anxiety). 37.2% of lorcaserin monotherapy group, 42.3% of the lorcaserin phentermine once daily group and 40.5% of the lorcaserin phentermine twice daily group reported potentially serotonergic adverse events. Headache and dry mouth were the most common adverse events. Adverse events leading to discontinuation were approximately double in the lorcaserin twice daily phentermine group compared to the lorcaserin monotherapy group. None of the potentially serotonergic adverse events were reported as serious and serotonin syndrome did not occur in any of the subjects. Mean weight loss was 3.3% in the lorcaserin monotherapy group, 6.7% in the lorcaserin phentermine once daily group and 7.2% in the lorcaserin phentermine twice daily group. A reduction of >5% of initial body weight was achieved in 28.2% of lorcaserin monotherapy subjects compared to 59.0% in lorcaserin phentermine once daily subjects and 70.9% in lorcaserin phentermine twice daily subjects.

This study evaluated combination pharmacotherapy with lorcaserin and phentermine which have distinct yet complimentary mechanisms of action. By targeting different signaling pathways, combination therapy has the potential to give better outcomes by overcoming adaptive mechanisms that can impede weight loss, thus improving efficacy. This study showed that the combination enhanced short-term weight loss but did not increase the incidence of potentially serotonergic adverse events. However, lorcaserin with twice daily phentermine did increase discontinuations compared to lorcaserin monotherapy and lorcaserin with once daily phentermine.

Author Scott Isaacs, MD Endocrinologist and Weight Loss Specialist

You Might Also Enjoy...

February is National Heart Health Month

Heart disease doesn’t happen just to older adults. It is happening to younger adults more and more often. This is partly because the conditions that lead to heart disease are happening at younger ages.

# 1 Again!

U.S. News & World Report has ranked the HMR program offered at Atlanta Endocrine Associates the #1 Best Fast-Weight Loss Diet for 2019. (41 different diet plans were evaluated.)

January is Healthy Resolutions Month

Some people's challenges are more daunting than others, and it can be disappointing when we abandon our resolutions after only a few weeks. No matter what you have resolved to do this year, it is always best to approach it with a plan.

HMR® at Home

HMR at Home® is an intensive weight loss program for people who are unable to attend the in-clinic HMR program and need a more flexible option. You can lose weight rapidly and build healthier routines that last with this home version of the HMR program.

Mindfulness-Based Eating Helps People Lose Weight

Obesity is a disease, not a lifestyle choice. Overeating is caused by out of control hunger hormones. Weight-gain and obesity can result from hormonal imbalance leading to chronic and maladaptive eating-related behaviors.

Atlanta Endocrine Associates
775 Johnson Ferry Road NE
Atlanta, GA 30342
Phone: 404-531-0350
Office Hours

Get in touch